Volume 77, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645


Immunosuppressed (cyclophosphamide) adult golden hamsters inoculated intraperitoneally (IP) with wild-type Asibi yellow fever virus (YFV) developed a rapidly fatal illness. Histopathologic and immunohistochemical studies of tissues from these animals showed typical hepatic changes of severe yellow fever (inflammation, hepatocyte necrosis, and steatosis) without brain involvement. In contrast, 50% of immunosuppressed hamsters receiving the YFV-17D–attenuated vaccine developed a slowly progressive encephalitic-type illness. Brain tissue from these latter animals revealed focal neuronal changes, inflammation, and YFV antigen–positive neurons; however, the liver and spleen appeared normal. YFV was isolated from brain cultures of many of these animals. Immunocompetent (non-immunosuppressed) hamsters inoculated with both viruses developed a subclinical infection. Results of this study indicate that wild-type YFV is hepatotropic in immunosuppressed hamsters, whereas the attenuated YFV-17 is primarily neurotropic. These findings support current recommendations against yellow fever vaccination of immunosuppressed/ immunocompromised people and suggest that this hamster model might be useful for monitoring the safety of other live-attenuated YFV vaccines.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Monath TP, 2004. Yellow fever vaccine. Plotkin SA, Orenstein WA, eds. Vaccines. Fourth edition. Philadelphia: Elsevier, 1095–1176.
  2. Barwick RS, Marfin AA, Cetron MS, 2004. Yellow fever vaccine-associated disease. Scheld WN, Murray BE, Hughes JM, eds. Emerging Infections 6. Washington: ASM Press, 25–34.
  3. Barnett ED, 2007. Yellow fever: epidemiology and prevention. Clin Infect Dis 44 : 850–856. [Google Scholar]
  4. Kengsakul K, Sathirapongsasuti K, Punyagupta S, 2002. Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection. J Med Assoc Thai 85 : 131–134. [Google Scholar]
  5. Centers for Disease Control and Prevention, 2002. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 51: 1–11. [Google Scholar]
  6. Ahmed AR, Hombal SM, 1984. Cyclophosphamide (Cytoxan*). J Am Acad Dermatol 11 : 1115–1126. [Google Scholar]
  7. Mateo R, Xiao S-Y, Guzman H, Travasssos da Rosa APA, Tesh RB, 2006. Effects of immunosuppression on West Nile virus infection in hamsters. Am J Trop Med Hyg 75 : 356–362. [Google Scholar]
  8. Tesh RB, Guzman H, Travassos da Rosa APA, Vasconcelos PFC, Dias LB, Bunnell JE, Zhang H, Xiao SY, 2001. Experimental yellow fever virus infection in the golden hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies. J Infect Dis 183 : 1431–1436. [Google Scholar]
  9. Tesh RB, 1979. A method for the isolation of dengue viruses, using mosquito cell cultures. Am J Trop Med Hyg 28 : 1053–1059. [Google Scholar]
  10. Clarke DH, Casals J, 1958. Techniques for hemagglutination and hemagglutination-inhibition of arthropod-borne viruses. Am J Trop Med Hyg 74 : 1084–1089. [Google Scholar]
  11. Xiao SY, Zhang H, Guzman H, Tesh RB, 2001. Experimental yellow fever virus infection in the golden hamster (Mesocricetus auratus). II. Pathology. J Infect Dis 183 : 1437–1444. [Google Scholar]
  12. Xiao SY, Guzman H, Zhang H, Travassos da Rosa APA, Tesh RB, 2001. West Nile virus infection in the golden hamster (Mesocricetus auratus): a model for West Nile encephalitis. Emerg Infect Dis 7 : 714–721. [Google Scholar]
  13. McArthur MA, Suderman MT, Mutebi JP, Xiao SY, Barrett ADT, 2003. Molecular characterization of a hamster viscerotropic strain of yellow fever virus. J Virol 77 : 1462–1468. [Google Scholar]
  14. McArthur MA, Xiao SY, Barrett ADT, 2005. Phenotypic and molecular characterization of non-lethal, hamster-viscerotropic strain of yellow fever virus. Virus Res 110 : 65–71. [Google Scholar]
  15. Bugher JC, 1951. The pathology of yellow fever. Strode GK, ed. Yellow Fever. New York: McGraw-Hill, 137–164.
  16. del Rio C, Meier FA, 1998. Yellow fever. Nelson AM, Horsburgh, Jr, eds. Pathology of Emerging Infections 2. Washington: ASM Press, 13–42.
  17. Sbrana E, Xiao S-Y, Popov VL, Newman PC, Tesh RB, 2006. Experimental yellow fever virus infection in the golden hamster (Mesocricetus auratus) III. Clinical laboratory values. Am J Trop Med Hyg 74 : 1084–1089. [Google Scholar]
  18. Sbrana E, Xiao SY, Guzman H, Ye M, Travassos da Rosa APA, Tesh RB, 2004. Efficacy of post-exposure treatment of yellow fever with ribavirin in a hamster model of the disease. Am J Trop Med Hyg 71 : 306–312. [Google Scholar]

Data & Media loading...

  • Received : 03 Nov 2006
  • Accepted : 19 Jul 2007

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error